Literature DB >> 23713087

Why our patients (and we) need basic science research.

Nina F Schor1.   

Abstract

In times of fiscal austerity, the tendency is to seek instant, inexpensive gratification. In the case of biomedical research, this means the shortest path to practical clinical implementation. But fueling the translational pipeline with discovery depends critically on allowing the biomedical research community to follow their science where it takes them. Fiscal constraints carry with them the risk of squelching creativity and forfeiting the power of serendipity to provide the substrate for the translational engine in the future.

Entities:  

Mesh:

Year:  2013        PMID: 23713087      PMCID: PMC3716401          DOI: 10.1212/WNL.0b013e318294b48a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  30 in total

1.  What the halted phase III γ-secretase inhibitor trial may (or may not) be telling us.

Authors:  Nina F Schor
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

2.  The trouble with translational medicine.

Authors:  Francesco M Marincola
Journal:  J Intern Med       Date:  2011-06-12       Impact factor: 8.989

3.  Transformative research: definitions, approaches and consequences.

Authors:  J T Trevors; Gerald H Pollack; Milton H Saier; Luke Masson
Journal:  Theory Biosci       Date:  2012-05-25       Impact factor: 1.919

4.  Expression and p75 neurotrophin receptor dependence of cholesterol synthetic enzymes in adult mouse brain.

Authors:  Zeljka Korade; Zhiping Mi; Carmel Portugal; Nina F Schor
Journal:  Neurobiol Aging       Date:  2006-08-02       Impact factor: 4.673

5.  The history of Parkinson's disease: early clinical descriptions and neurological therapies.

Authors:  Christopher G Goetz
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

6.  Multimodal neuroprotection induced by PACAP38 in oxygen-glucose deprivation and middle cerebral artery occlusion stroke models.

Authors:  Philip Lazarovici; Gadi Cohen; Hadar Arien-Zakay; Jieli Chen; Chunling Zhang; Michael Chopp; Hao Jiang
Journal:  J Mol Neurosci       Date:  2012-06-08       Impact factor: 3.444

Review 7.  MicroRNAs shape the neuronal landscape.

Authors:  Elizabeth McNeill; David Van Vactor
Journal:  Neuron       Date:  2012-08-09       Impact factor: 17.173

8.  Chronic hypobaric hypoxia induced apoptosis in CA1 region of hippocampus: a possible role of NMDAR mediated p75NTR upregulation.

Authors:  Sunil K Hota; Kalpana Barhwal; Shashi B Singh; G Ilavazhagan
Journal:  Exp Neurol       Date:  2008-02-16       Impact factor: 5.330

9.  Chance and serendipity in science: two examples from my own career.

Authors:  Daniel Steinberg
Journal:  J Biol Chem       Date:  2011-09-09       Impact factor: 5.157

10.  Targeting nuclear RNA for in vivo correction of myotonic dystrophy.

Authors:  Thurman M Wheeler; Andrew J Leger; Sanjay K Pandey; A Robert MacLeod; Masayuki Nakamori; Seng H Cheng; Bruce M Wentworth; C Frank Bennett; Charles A Thornton
Journal:  Nature       Date:  2012-08-02       Impact factor: 49.962

View more
  2 in total

1.  Phase-In to Phase-Out-Targeted, Inclusive Strategies Are Needed to Enable Full Replacement of Animal Use in the European Union.

Authors:  Lindsay J Marshall; Helder Constantino; Troy Seidle
Journal:  Animals (Basel)       Date:  2022-03-29       Impact factor: 2.752

2.  The Symbiotic Relationship Between Scientific Quality and Animal Research Ethics.

Authors:  Samuel A Brill; Selena M Guerrero-Martin; Kelly A Metcalf Pate
Journal:  ILAR J       Date:  2021-09-24       Impact factor: 1.521

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.